 |
|
2q37 Deletion syndrome confirmed by high-resolution cytogenetic analysis
Eun-Kyung Cho, Jinsup Kim, Aram Yang, Sung Yoon Cho, Dong-Kyu Jin
Ann Pediatr Endocrinol Metab. 2017;22(2):129-132. Published online 2017 Jun 28 DOI: https://doi.org/10.6065/apem.2017.22.2.129
|
|
Citations to this article as recorded by
 Genotype–Phenotype Correlations in 2q37-Deletion Syndrome: An Update of the Clinical Spectrum and Literature Review
Eva-Cristiana Gavril, Irina Nucă, Monica-Cristina Pânzaru, Anca Viorica Ivanov, Cosmin-Teodor Mihai, Lucian-Mihai Antoci, Cristian-Gabriel Ciobanu, Cristina Rusu, Roxana Popescu
Genes.2023; 14(2): 465. CrossRef A rare case of 2q37 deletion syndrome presented with patent foramen ovale
Ahmed Zaki, Nour Shaheen, Mohamed Hosny, Abdelraouf Ramadan, Abdulqadir J. Nashwan
Clinical Case Reports.2023;[Epub] CrossRef A Cytogenetic Study of Turkish Children with Global Developmental Delay
Osman Demirhan, Özlem Hergüner, Erdal Tunç
Journal of Pediatric Genetics.2022;[Epub] CrossRef Genotype and phenotype correlation in 103 individuals with 2q37 deletion syndrome reveals incomplete penetrance and supports HDAC4 as the primary genetic contributor
Trang N. Le, Stephen R. Williams, Joseph T. Alaimo, Sarah H. Elsea
American Journal of Medical Genetics Part A.2019; 179(5): 782. CrossRef Brachydactyly mental retardation syndrome with growth hormone deficiency
Alireza Arefzadeh, Pooyan Khalighinejad, Bahar Ataeinia, Pegah Parvar
Endocrinology, Diabetes & Metabolism Case Reports.2018;[Epub] CrossRef
|